Framework for Fair, Equitable and Timely Allocation of COVID-19 Vaccines in Africa

  • Version
  • Download 4672
  • File Size 351.57 KB
  • File Count 1
  • Create Date 31 January 2021
  • Last Updated 19 February 2021

Framework for Fair, Equitable and Timely Allocation of COVID-19 Vaccines in Africa

1. Background

Coronavirus Disease 2019 (COVID-19) is a viral disease caused by Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Since the detection of the first
cases of COVID-19 in late 2019, the disease has become a global emergency with severe implications on lives and livelihoods worldwide. As of January 2021,
COVID-19 has killed 2.2 million people globally and infected more than 100 million.
The virus has devastated the global economy and severely harmed critical pillars of society, including the provision of education and healthcare, and community
activities that are key for physical and mental health. The African continent is no exception. African Union Member States have confirmed almost 90,000 COVID-19 deaths and more than 3.4 million infections. Africa is facing its first recession in 25 years due to the pandemic, with the informal sector (making up 70% of the economy) being the hardest hit. Recession is driven by the contraction of global trade as well as declining continental and domestic economic activities. Research indicates that the pandemic is endangering the success of decades of work towards the achievement of the African development agenda.

 

Attached Files

FileAction
Framework for Fair Allocation of Vaccines - ENGDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload